ROSTOCK and BERLIN, Germany – (Arab Newswire) — arcensus GmbH is proud to announce the launch of its direct-to-consumer myLifeHeart
Diseases of the heart and blood vessels are a major cause of morbidity and mortality worldwide. Up to 18 million people, including even 1% of completely healthy and active athletes, die every year from these disorders. Public prevention strategies have relied on managing environmental factors that contribute to cardiac diseases, such as obesity, smoking, and lack of exercise. However, the crucial role of genetics in heart diseases has just recently become evident.
Many genetic heart disorders can be successfully treated if identified early. Numerous national and international societies of cardiovascular specialists such as the American Heart Association, the European Heart Rhythm Association, and the American College of Medical Genetics and Genomics recommend genetic testing to diagnose cardiac disorders. However, most of the affected individuals have a long diagnostic odyssey including multiple hospital admissions, as well as expensive and invasive clinical investigations. To address this issue, arcensus created an innovative product, myLifeHeart
arcensus GmbH offers sophisticated genomics testing and preventive health services to give all individuals certainty and actionable insights about their health. The basis of the knowledge-generating direct-to-consumer business is an innovative WGS strategy. WGS captures all genetic variants that are missed in single gene or panel testing. The direct-to-consumer business model allows the early identification of individuals suffering from a potential genetic disorder or those at risk for such problems. Such a strategy is particularly valuable when diseases are life-threatening or even fatal as sudden death or aortic dissection at their first presentation.
From our headquarters in Rostock and Berlin, Germany, a cross-functional team of genetic experts, medical doctors, and data scientists work to make the most sophisticated and best genetic interpretation with medical and health prevention applications accessible to everyone.
For more information, visit https://arcensus-diagnostics.com/ and follow us on our social channels and Youtube.
Chief of Staff
This press release is issued through Arab Newswire